NIH Launches Trial to Evaluate Long-acting HIV Medication in People Unable to Adhere to Strict Daily Regimens

May 20, 2019 | Kim Rodgers

The National Institutes of Health has launched the Long-Acting Therapy to Improve Treatment Success in Daily Life (LATITUDE) study, which compares monthly injectable antiretroviral therapy to daily oral drugs in people unable to adhere to strict daily regimens. The trial is funded by the National Institute of Allergy and Infectious and will be conducted by the AIDS Clinical Trials Group with support from the National Institute of Mental Health, the National Institute on Drug Abuse, ViiV Healthcare, and the Janssen Pharmaceutical Companies of Johnson & Johnson.

The trial will evaluate two experimental, long-acting injections of the antiretroviral drugs rilpivirine and cabotegravir, which will be administered every four weeks by a healthcare professional in a research clinic. Throughout the study, investigators will evaluate volunteers’ viral load—the measure of virus in the blood—and other indicators of immune health to compare the treatment’s effectiveness to that of conventional oral ART.

Learn more about the study.


About Kim Rodgers

Pronouns: She/Her

Kim Rodgers was formerly the Communications Manager at NACCHO.

More posts by Kim Rodgers

Related Posts

I Stock 1182682774
  • Adverse Childhood Experiences (ACEs)
  • Behavioral Health
  • Community Health
  • Injury and Violence Prevention

Seeking LHD Participants for an Intersectional Data...

With support from the Centers for Disease Control and Prevention, NACCHO is...

Mar 26, 2024 | Camille Adams

Seeking LHD Participants for an Intersectional Data...

World TB Day 2024 1
  • ID Featured
  • Infectious Disease
  • Tuberculosis

Recognizing World TB Day 2024: The Role of Local Health...

LHDs across the nation actively work to eliminate TB through surveillance, case...

Mar 21, 2024 | Kimberly Nalley

Recognizing World TB Day 2024: The Role of Local Health...

I Stock 1318852282
  • COVID-19
  • Immunization
  • Infectious Disease
  • Influenza

Maternal and Child Vaccine Safety - Enhancing Vaccine...

After conducting a Rapid Community Assessment (RCA), in collaboration with the...

Mar 19, 2024 | Victoria Thompson, Clarissa Montes

Maternal and Child Vaccine Safety - Enhancing Vaccine...

Measles Blog 1
  • Tools & Resources
  • Community Health
  • ID Featured
  • Immunization

The Current Status of Measles in the US + Resources to...

This resource round-up aims to help local health departments and healthcare...

Mar 18, 2024 | Irene Halferty, Emma James, Victoria Thompson, Amy Maxson, Robin Mowson

The Current Status of Measles in the US + Resources to...

1

Building Community Resilience Through Maternal and Child...

NACCHO, with funding from the Centers for Disease Control and Prevention’s...

Mar 15, 2024 | Elana Filipos

Building Community Resilience Through Maternal and Child...

  • HIV, STI, & Viral Hepatitis

CDC Study Reveals Increase in Overdoses Associated with...

A recent CDC study demonstrates a need for LHDs and other local harm reduction...

Mar 14, 2024 | Kat Kelley, Anjana Rao, Grace Murtha

CDC Study Reveals Increase in Overdoses Associated with...

1

Bridging Maternal-Child Health (MCH), Infectious Disease...

Funded through the Center for Disease Control and Prevention’s (CDC) National...

Mar 12, 2024 | Elana Filipos

Bridging Maternal-Child Health (MCH), Infectious Disease...

Thumbnail youtube
  • Tools & Resources
  • Adverse Childhood Experiences (ACEs)

NACCHO Releases “Community Partnerships to Prevent...

The National Association of County and City Health Officials is pleased to...

Mar 12, 2024 | Camille Adams

NACCHO Releases “Community Partnerships to Prevent...

1
  • Maternal, Child, & Adolescent Health

NACCHO Provides Funding to Local Health Departments to...

The Maternal, Child, and Adolescent Health team has selected 14 new local...

Mar 11, 2024 | Ryanna Quazi

NACCHO Provides Funding to Local Health Departments to...

Back to Top